HomeTOP STORIESADC Therapeutics targets $600M–$1B in peak ZYNLONTA revenue amid expansion into DLBCL... ADC Therapeutics targets $600M–$1B in peak ZYNLONTA revenue amid expansion into DLBCL market By rogerjudd March 27, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleBiggest stock movers Thursday: GM, GME, SLNO, ME, and moreNext articleMannatech GAAP EPS of $1.20, revenue of $29M latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
